Press Releases

Fusion Biopsy Market is Anticipated to Grow US$ 3.12 Bn By 2030

Share This Article

According to the Vision Research Reports, the Global Fusion Biopsy market size was valued at USD 589.1 billion in 2020 and is projected to reach US$ 3.12 billion by 2030, growing at a CAGR of 13.6% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38468

Growth Factors

Increasing prevalence of prostate cancer, growing awareness about the importance of regular clinical interventions, and developing reimbursement policies are factors likely to boost the demand for targeted MR/ultrasound biopsy systems over the forecast period. An increasing number of radiologists gaining expertise in interpreting prostate MRI coupled with the implementation of standard image grading systems such as PI-RADS and Gleason score has increased the utilization rate of targeted MR/Ultrasound fusion biopsy systems.

Report Highlights

The transrectal segment dominated the market for fusion biopsy and accounted for the largest revenue share of 96.7% in 2020 because it was considered as the gold standard in performing prostate biopsy worldwide in the past decades. Most of the commercially available fusion biopsy was limited to the transrectal approach, contributing to its largest market share.

Transperineal fusion biopsy is an emerging trend and is expected to experience the fastest CAGR of 25.2% during the forecast period. Lower risk of infection and rectal bleeding in comparison to the traditional approach is expected to contribute towards the segment growth.

The hospitals segment dominated the market for fusion biopsy and held the largest revenue share of 71.0% in 2020 owing to their high purchasing power. The average unit price of a fusion biopsy system is expensive, making it unaffordable for private diagnostic centers.

The diagnostics centers segment is expected to grow at a significant rate in the market for fusion biopsy over the forecast period. Shorter wait times, cost efficiency, and a developing reimbursement paradigm are the factors expected to drive the growth of this segment.

The ambulatory care centers segment is expected to grow at the fastest rate of 22.6% during the forecast period. The rising prevalence of prostate cancer in rural areas having limited access to healthcare services is the factor expected to drive the growth of the segment.

North America dominated the market for fusion biopsy and accounted for the largest revenue share of 56.2% in 2020 and is expected to continue its dominance over the forecast period. The Asia Pacific is anticipated to register the fastest growth in the fusion biopsy market. The presence of key players, increase in the incidence of prostate cancer, and development of healthcare infrastructure are factors likely to propel market growth.

In Asia Pacific, the market for fusion biopsy is anticipated to witness a CAGR of 22.0% during the forecast period. The Asia Pacific exhibits a lucrative growth opportunity with the emerging economies at the forefront of development. The major factors driving the growth of the market include rising awareness of prostate cancer, increasing population base, and rising disposable income levels as well as high unmet needs of the patients in emerging countries such as India,

Key Players

  • MedCom
  • ESAOTE SPA
  • KOELIS
  • Focal Healthcare
  • GeoScan Medical
  • UC-Care Medical Systems Ltd.
Report Coverage Details
Market Size US$ 3.12 billion by 2030
Growth Rate CAGR of 13.6% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Biopsy Route, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Eigen; Koninklijke Philips N.V.; Hitachi, Ltd.; MedCom; ESAOTE SPA; KOELIS; Focal Healthcare; UC-Care Medical Systems Ltd.; GeoScan Medical

Market Segmentation

  • Biopsy Route
    • Transrectal
    • Transperineal
  • End-use
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Care Centers
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Switzerland
      • Belgium
    • Asia Pacific
      • China
      • Japan
      • India
      • Thailand
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38468

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Fusion Biopsy Market, By Biopsy Route

7.1.  Fusion Biopsy Market, by Biopsy Route, 2021-2030

7.1.1.    Transrectal

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Transperineal

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Fusion Biopsy Market, By End-use

8.1.  Fusion Biopsy Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Diagnostic Centers

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Ambulatory Care Centers

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Fusion Biopsy Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

Chapter 10.  Company Profiles

10.1.              MedCom

10.1.1.  Company Overview

10.1.2.  Biopsy Route Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              ESAOTE SPA

10.2.1.  Company Overview

10.2.2.  Biopsy Route Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              KOELIS

10.3.1.  Company Overview

10.3.2.  Biopsy Route Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Focal Healthcare

10.4.1.  Company Overview

10.4.2.  Biopsy Route Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              GeoScan Medical

10.5.1.  Company Overview

10.5.2.  Biopsy Route Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              UC-Care Medical Systems Ltd.

10.6.1.  Company Overview

10.6.2.  Biopsy Route Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38468

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button